Animal models of dyssynchrony

Marc Strik1, Lars B van Middendorp, Kevin Vernooy

  • 1Department of Physiology, Cardiovascular Research Institute Maastricht, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands. m.strik@maastrichtuniversity.nl

Insights

Cardiac resynchronization therapy (CRT) benefits heart failure patients, but responses vary. This review explores how animal models can clarify conduction disease and improve CRT effectiveness.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Animal Models

Background:

  • Cardiac resynchronization therapy (CRT) is crucial for heart failure patients with conduction issues.
  • A significant portion of patients (around one-third) do not respond to CRT, indicating a need for better understanding.
  • Patient response to CRT is heterogeneous, highlighting variability in underlying conduction disease.

Purpose of the Study:

  • To review the utility of animal models in understanding cardiac dyssynchrony pathophysiology.
  • To explore how animal models can elucidate the mechanisms behind CRT response heterogeneity.
  • To assess the potential of established and novel animal models for advancing CRT research.

Main Methods:

  • Literature review of established and novel animal models relevant to cardiac dyssynchrony.
  • Analysis of studies investigating the pathophysiology of conduction disease in animal models.
  • Examination of research utilizing animal models to assess CRT efficacy and mechanisms.

Main Results:

  • Animal models offer valuable insights into the complex pathophysiology of cardiac dyssynchrony.
  • These models aid in dissecting the electrophysiological basis of CRT response.
  • Variability in animal model responses may mirror clinical heterogeneity, providing predictive potential.

Conclusions:

  • Animal models are essential tools for unraveling the complexities of cardiac dyssynchrony.
  • Further development and application of animal models can improve patient selection and CRT optimization.
  • Understanding dyssynchrony through animal studies is key to enhancing CRT benefits for heart failure patients.